Biogen Idec to Present at the Bear Stearns Healthcare Conference …Financial News USA (press release), CA - 3 hours agoShares of Biotechnology Company Amgen Inc. (Nasdaq:AMGN) recently rose following a move by the US Senate to pass a resolution requesting the Centers for …
Read full story
Amgen (AMGN) gets favorable Senate actionBloggingStocks - 23 hours agoAmgen Inc. (NASDAQ: AMGN) is higher today on reports that the US Senate has passed a resolution requesting that the Centers for Medicare & Medicaid Services …Amgen (AMGN): A trading buy in biotech Blogging Stocksall 2 news articles
Read full story
Roche's Humer Sticks to $3 Billion Bid for Ventana (Update1)Bloomberg - 8 hours agoHumer also said he remains confident of prevailing in a legal tussle with Amgen Inc., the world's biggest biotechnology company, over Roche's new anemia …
Read full story
Aranesp Study Showing No Negative Impact on Survival in SCLC …PharmaLive.com (press release), PA - 3 hours ago(WCLC Poster #PD6-3-6) This study is a component of Amgen's ongoing pharmacovigilance program designed to evaluate the effect of Aranesp on long-term …LCA Hails International Investigators Studying Lung Cancer Earthtimes.orgall 7 news articles
Read full story
Senators aid Amgen's claim with MedicareLos Angeles Times, CA - 10 hours agoBy Daniel Costello, Los Angeles Times Staff Writer In a boost for troubled Amgen Inc., the Senate called on federal Medicare regulators to reassess a recent …BIOTECH STOCKS Amgen rises on Senate resolution; sectors mixed MarketWatchAmgen and Genentech Brace Themselves for Heavy Pressure From … PR Newswire (press release)all 7 news articles
Read full story
Amgen, Roche lay out opening arguments in trialReuters - 20 hours agoFacing off in US District Court in Boston, Amgen, the world's biggest biotechnology company, is seeking to prove that Roche's product infringes its patents. …Amgen shares up as lawmakers enter anemia drug row ReutersAmgen stock rises on Senate move CNNMoney.comSenators boost Amgen's battle to overturn Medicare restrictions Pharma Times (subscription)Rocky Mountain News - The Deal Blogsall 9 news articles
Read full story
Dykstra: Sail to Amgen's Safe HarborTheStreet.com - 1 hour agoWith this uncertainty still in the air, now's the perfect time to return to one of my favorites, Amgen (AMGN - Cramer's Take - Stockpickr). …
Read full story
Amgen Shares Rise on Senate ResolutionForbes, NY - 2 hours agoAP 09.05.07, 10:39 AM ET Shares of biotechnology company Amgen Inc. rose Wednesday following a move by the US Senate to pass a resolution requesting the …Head to Court On Anemia Drug Wall Street Journalall 10 news articles
Read full story
Amgen stock rises on Senate moveCNNMoney.com - 13 minutes agoUS Senate asks that restrictions on Medicaid, Medicare coverage of anti-anemia drugs be lifted, analysts say; Amgen court fight vs. Roche over patents looms …
Read full story
BIOTECH STOCKS Amgen rises on Senate resolution; sectors mixedMarketWatch - 2 hours agoBy Russ Britt, MarketWatch LOS ANGELES (MarketWatch) — A call from the Senate to re-examine whether Amgen's cancer drugs should be reconsidered for …Amgen and Genentech Brace Themselves for Heavy Pressure From … PR Newswire (press release)all 4 news articles
Read full story
Amgen Foundation Awards Grant to Mentor LA to Help Improve Public …Business Wire (press release), CA - 1 hour agoThe Amgen Foundation grant of $4 million over three years will assist MLA in advancing a new model of high performance public schooling, one where the …LAUSD to readjust needs as enrollment changes Los Angeles Daily Newsall 3 news articles
Read full story
Amgen (AMGN): A trading buy in biotechBlogging Stocks - 22 hours agoHe continues, "Amgen recently traded down to over four-year lows in response to a barrage of negative news flow. The investment community has punished the …
Read full story
Pharmaceutical Group Paid Lobbyist $100KForbes, NY - 1 hour agoThe trade group, whose members include Amgen Inc., Eli Lilly & Co. and Pfizer Inc., lobbied on patent reform, according to the form posted online Aug. …
Read full story
Investment banksFinancial Times, UK - 7 hours agoAs brokerage firms tot up the damage from the financial hurricane that hit Wall Street this summer, investors are braced for some messy results. …Earnings Best Barron’s (subscription)Value Play Lifts Brokerages Into Labor Day Forbesall 6 news articles
Read full story
Amgen, Roche prepare for anemia drug trialReuters - Aug 31, 2007VX: Quote, Profile, Research) anemia drug Mircera infringes patents on Amgen's rival drugs Epogen and Aranesp. The jury trial, set to begin Sept. …
Read full story
Doctors Aim to Loosen Anemia Drug LimitsForbes, NY - Aug 31, 2007Physicians use Amgen's Aranesp and Johnson and Johnson's Procrit to raise patients' red blood cell levels. "Some of our members are being forced to turn …Cancer Doctors Seek New Drug Limits Los Angeles Business Journal (subscription)all 74 news articles
Read full story
Amgen Paid Lobbyist $120000Forbes, NY - Aug 31, 2007AP 08.31.07, 11:53 AM ET Drug maker Amgen Inc. paid Lent Scrivner & Roth LLC to lobby the federal government in the first half of 2007, according to a …
Read full story
Amgen paid lobbyist $120000CNNMoney.com - Aug 31, 2007Conrad Burns, R-Mont., is among those registered to lobby on behalf of Amgen. Under a federal law enacted in 1995, lobbyists are required to disclose …
Read full story
Amgen's Worst Year to Darken as US May Curb Use of Top DrugsBloomberg - Aug 29, 200729 (Bloomberg) — Amgen Inc. may be headed for the worst annual decline in the stock's 24-year history as US regulators consider restricting use of its …
Read full story
Amgen Vindicated In Drug Patent SuitForbes, NY - Aug 29, 2007Amgen investors cheered, as shares of Amgen rose 2.4%, or $1.18 cents, to $50.19 at the closing bell. Although the trial is far from over, the court agreed …
Read full story